Navigation Links
Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer

NEW YORK, July 12, 2007 /PRNewswire-FirstCall/ -- ImClone Systems Incorporated and Bristol-Myers Squibb Company today announced results from an open-label Phase III study of ERBITUX(R) (Cetuximab) plus a taxane and carboplatin in the first-line treatment for metastatic non-small cell lung cancer (NSCLC). The study did not meet its primary endpoint of progression-free survival (PFS) as assessed by an independent radiology review committee (IRRC). However, key secondary endpoints of the study, including response rate as assessed by the IRRC and PFS as assessed by clinical investigators, were statistically significant and favored the ERBITUX- containing arm.

Known as BMS CA225-099, this study included more than 600 patients from the United States and Canada and was one of several clinical trials intended to establish the role of ERBITUX in the treatment of advanced NSCLC. Data from the largest of these trials, an ongoing multinational Phase III study of ERBITUX plus cisplatin and vinorelbine intended to be the pivotal study for the ERBITUX NSCLC regulatory strategy, are not yet available.

"We consider lung cancer to be a high priority and await the results of other Phase II and Phase III evaluations of ERBITUX in the first- and second- line setting with chemotherapy regimens," stated Eric K. Rowinsky, M.D., Chief Medical Officer and Senior Vice President of ImClone Systems.

"Lung cancer is a devastating disease with few effective treatment options," said Martin Birkhofer, M.D., Vice President, Oncology Global Medical Affairs, Bristol-Myers Squibb. "Efforts to fully interpret these results are ongoing, and the companies plan to submit the data from this study to an upcoming medical meeting in 2007."

About Lung Cancer

The American Cancer Society estimates that in the U.S., more than 213,000 people will be diagnosed with lung cancer in 2007. Lung cancer is the leading cause of cance
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
2. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
3. Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
4. Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
5. Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
6. Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting
7. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
8. Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:9/15/2014)... Fla. , Sept. 15, 2014 myMatrixx ... Steven Stanos with an expanded role that ... Dr. Stanos, a nationally recognized physiatrist and ... topics related to rehabilitation and workers, compensation, is Board ... by the American Board of Pain Medicine and subspecialty ...
(Date:9/15/2014)... PDL BioPharma, Inc. (PDL) (NASDAQ: ... September 12, 2014, regular quarterly dividend payment of $0.15 per ... of September 5, 2014, the record date. ... portfolio of patents and royalty assets, consisting primarily of ... agreements with various biotechnology and pharmaceutical companies. PDL pioneered ...
(Date:9/15/2014)... DUBLIN , Sept. 15, 2014 Research ... "The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition" ... volume covers the entirety of the clinical testing market and ... Used by Top IVD Companies For Business Planning. ... volume based on the market events of 2013 and early ...
Breaking Medicine Technology:myMatrixx Announces Expanded Role for Medical Director Steven P. Stanos, Jr., DO 2PDL BioPharma Completes Regular Quarterly Dividend Payment 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 3
... NEW YORK, June 16, 2011 Reportlinker.com announces ... in its catalogue: US Wound ... http://www.reportlinker.com/p0555195/US-Wound-Closure-Devices-–-Market-Trend-Till-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment ... provides vital market data on the wound closure ...
... New research adds to the growing body of ... thermometry provides reliable and accurate temperature readings. The ... enhancing patient outcomes conducted within a 558-bed community-based ... electronic (OE) thermometers both are reasonable options. The ...
Cached Medicine Technology:Reportlinker Adds US Wound Closure Devices - Market Trend Till 2016 2Research Led by Clinical Nurse Specialists Reconfirms Reliability of Temporal Artery Thermometry 2
(Date:9/15/2014)... -- U.S. heart experts recommend doctors use a 14-point ... people for underlying heart disease that could result in ... the American College of Cardiology said in a joint ... history along with a physical examination can help identify ... risks for sudden cardiac death. The statement, ...
(Date:9/15/2014)... 2014 “Canada Gynecological Devices Market ... the Canada Gynecological Devices market. The report provides ... units) and average prices (in US dollars) within ... Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical ... Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation ...
(Date:9/15/2014)... HealthDay Reporter MONDAY, Sept. ... twice as often as they,re actually needed for children ... More than 11 million antibiotic prescriptions written each ... to researchers from University of Washington and Seattle Children,s ... eradicate children,s viral illnesses, researchers said, but supports the ...
(Date:9/15/2014)... 15, 2014 As Colorado's historic ... its first full year, there are a variety ... in the evolution of its marketing and branding. ... taken by Denver's Kindman, one of the state's ... , Kindman has pioneered the first-ever branded and ...
(Date:9/15/2014)... Physicians and clinicians from around ... at the Lowes Coronado Bay Resort for the ... . This CME accredited medical conference ... healthcare professionals—about the nutritional science that overwhelmingly supports ... its proven ability to prevent, suspend and, often, ...
Breaking Medicine News(10 mins):Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 3Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 2Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 3Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 2Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 3
... It,s long been known that obesity increases diabetes risk, but ... someone carries -- and how long it,s carried -- can ... the growing number of obese children and teens who will ... researchers from the University of Michigan Health System warn in ...
... 2011) More part-time employment for surgeons, particularly retiring older ... families, may considerably reduce the surgeon shortage in the United ... September issue of the Journal of the American College ... gaining popularity among Generation X (currently ages 30 through early ...
... HealthDay Reporter , SUNDAY, Sept. 11 (HealthDay News) -- ... of Pearl Harbor still packs a psychological punch for many ... serves as the moment when a stunned young country shed ... stage with the now-iconic can-do bravado of the "Greatest Generation." ...
... The Journal of Emergency Medical Services (JEMS) today announces ... featuring first-person accounts of responders who were thrust into ... when terrorists invaded their response districts and their ... responders throughout the world, think, train, respond and live ...
... FRIDAY, Sept. 9 (HealthDay News) -- Almost half of all ... the months following the 9/11 terrorist attacks still struggle with ... Harris Interactive/HealthDay poll found. The most common ... 24 percent of those still affected, and anxiety, by 13 ...
... , ROCHESTER, Minn. -- Mayo Clinic researchers have developed a ... to combat human HIV/AIDS and other diseases. The goal is ... virus. The findings -- called fascinating and landmark by one ... Nature Methods . Feline immunodeficiency ...
Cached Medicine News:Health News:Lifetime 'Dose' of Excess Weight Linked to Diabetes Risk 2Health News:Allowing part-time surgeons may help address workforce shortage 2Health News:9/11 Left Permanent Scars on the American Psyche 2Health News:9/11 Left Permanent Scars on the American Psyche 3Health News:9/11 Left Permanent Scars on the American Psyche 4Health News:9/11 Left Permanent Scars on the American Psyche 5Health News:9/11 Left Permanent Scars on the American Psyche 6Health News:Out of the darkness 2Health News:For Many Americans, 9/11 Worries Still Dominate 2Health News:For Many Americans, 9/11 Worries Still Dominate 3Health News:Mayo Clinic teams with glowing cats against AIDS, other diseases 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: